Cancer Profile in West Jakarta: A 5-year descriptive study

Soehartati Argadikoesoema Gondhowiardjo, Denny Handoyo, Mahesa Auzan, Sri Mutya Sekarutami, Nadia Christina, Steven Octavianus, R. Koesmedi Priharto, - Widyastuti

Sari


Background. Cancer burdens the government in terms of health care funding.     Unlike  Indonesia, cancer information and data in other several countries are handled by a program called The National Program of Cancer Registries (NPCR), managed by the Centers for Disease Control and Prevention (CDC). This study was aimed to describe the cancer profile in West Jakarta Region from 2008 to 2012 due to insufficient data provided by the government.

Methods. This was a cross-sectional, descriptive study involving all cancer patients residing in West Jakarta based on the medical record of Cipto Mangunkusumo    Hospital, acting as DKI Jakarta Cancer Registry Control Center.

Results This study found 4,057 cancer cases in the area. Five most commonly       diagnosed cancer cases based on the sites of disease are breast cancer (22,5%), cervical cancer (10,3%), lung and bronchus cancer (7,5%), nasopharyngeal cancer (5,3%), and hemopoietic and reticuloendothelial malignancies (5,3%). Most cases were diagnosed in advance stage (III and IV) and predominantly in women aged 45 – 54 years old. Intraductal carcinoma was the most common morphology type for breast cancer cases.


Kata Kunci


2008-2012, cancer profile, Cipto Mangunkusumo, West Jakarta

Teks Lengkap:

PDF (English)

Referensi


American Cancer Society. Global Cancer Facts and Figures 3rd Edition. Atlanta: American Cancer Society; 2015.

Oemiati R, Rahajeng E, Kristanto AY. Prevalensi Tumor dan Beberapa Faktor yang Mempengaruhinya di Indonesia. Buletin Penelitian Kesehatan. 2011; Jakarta 39(4):190-204

Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tuilent J, Jemal A. Global Cancer Statistic, 2012. CA Cancer J Clin. 2015 Maret; 65(2): 87-108.

IARC. The Globocan Project http://globocan.iarc.fr/Default.aspx (2010, accessed 1 January 2016).

dharmais.co.id [Internet]. Jakarta: RS Kanker Dharmais. [cited 2016]. Available from http://dharmais.co.id/page/113/Pengantar

Philippine Cancer Society. Philippine Cancer Facts and Estimates 2010. Manila: Philippine Cancer Society. 2010.

Ministry of Health Malaysia. Summary of Malaysian National Cancer Registry Report 2007-2011. Putrajaya: National Cancer Registry Department, National Cancer Institute, Ministry of Health.

Brohet KE, Gondhowiardjo S. Profil Epidemiologi Kanker di Rumah Sakit Cipto Mangunkusumo berdasarkan Hospital Based Cancer Registry RSCM tahun 2013.

Meidania L. Profil Karsinoma Nasofaring Berdasarkan Registrasi Kanker Berbasis Rumah Sakit Di Rsupn Cipto Mangunkusumo Periode Januari-Desember 2013.

Kementerian Kesehatan RI. Infodatin: Situasi Penyakit Kanker. Jakarta: Pusat Data dan Informasi Kementerian Kesehatan RI; 2015 [cited ]; Available from: http://www.depkes.go.id/resources/download/pusdatin/infodatin/infodatin-kanker.pdf

Singapore Cancer Registry. Cancer Incidence and Mortality 2003 – 2012 and Selected Trends 1973 – 2012 in Singapore. Singapore: National Registry Diseases Office; 2015. [cited]; Available From https://www.nrdo.gov.sg/docs/ librariesprovider3/default-document-library/cancertrends_7312_web128e09a5c9d76bafab5aff000014cdee.pdf?sfvrsn=0

Hristov B. Radiation Oncology: A Question-Based Review. 2nd. Philadelphia: Lippincott Williams and Wilkins; 2015.

Rahman S, Budiman BJ, Subroto H. Faktor Risiko Non Viral Pada Karsinoma Nasofaring. J Kesehat Andalas. 2015; 4: 988–95.

Kementerian Kesehatan RI. Pedoman Penemuan Dini Kanker pada Anak. Jakarta: Direktorat Jenderal Pengendalian Penyakit Tidak Menular; 2011 [cited]; Available from http:// p2ptm.kemkes.go.id/dokumen-ptm/pedoman-penemuan-dini-kanker-pada-anak




DOI: https://doi.org/10.32532/jori.v9i2.94 <

Article metrics

Abstract views : 382 | views : 349

Refbacks

  • Saat ini tidak ada refbacks.




  

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.